We have read with interest the article by Weitzenblum et al (Chest 1994;105:1377-82) concerning pulmonary hemodynamic changes associated with the development of peripheral edema in patients with COPD. The authors found that two groups of patients could be identified: those with evidence of right ventricular failure and those without during the period of decompensation. Neither group had evidence of cardiac dysfunction at baseline.
Correlate Clinical Findings With Hemodynamic Findings
To the Editor:
We have read with interest the article by Weitzenblum et al (Chest 1994; 105:1377-82) concerning pulmonary hemodynamic changes associated with the development of peripheral edema in patients with COPD. The authors found that two groups of patients could be identified: those with evidence of right ventricular failure and those without during the period of decompensation. Neither group had evidence of cardiac dysfunction at baseline.
Although statistical analysis confirmed the difference in hemodynamic parameters and outcome between the two groups during a period of "decompensation" with edema, it appears that those in group 1 were heavier (70.6 ± 16.1 kg vs 57 ± 13.3 kg) and had evidence of more CO2 retention (46 ± 7 mm Hg vs 42 ± 6 mm Hg) at base line.
In the article, no attempt was made to correlate clinical findings other than the development of peripheral edema during the study. Could it be that groups 1 and 2 consisted of "blue bloater" and "pink puffer" varieties of COPD respectively? Further investigation of the correlation between right ventricular failure and peripheral edema in patients with COPD with respect to the clinical classification may be helpful. We appreciated the comments by Drs. Seneviratne and Kupfer. They emphasized the fact that the body weight at baseline (Ti) was higher in patients of group 1. Patients of group 1 had also, at baseline, a higher PaCO2 and a lower PaO2, even though these differences were not statistically significant. Baseline pulmonary artery pressure was also higher in group 1 (27 ± 5 vs 20 ± 6 mm Hg). We agree that the majority of group 1 patients, but not all individual patients, were probably of the "blue bloater" type whereas most of group 2 patients, but not all individual patients, were probably of the "pink puffer" type of COPD. Almost all patients, in both groups, had a history of chronic bronchitis plus radiologic and functional signs of emphysema. With the purpose of studying the relationship between asthma mortality and drugs in Greece, we correlated the annual deaths from asthma with the consumption of antiasthmatic drugs for 13 years (1979 to 1991). All deaths from asthma attacks were recorded under the code 493, which included atopic or nonatopic asthma. We studied the deaths in the 5 to 64-year-old age group, because some deaths in the neonatal or elderly age groups may be from another disease in addition to asthma. 
